Poloxin-2 is a small-molecule inhibitor of the Plk1 PBD (Polo-box domain), effectively inducing mitotic arrest in cells with an EC50 of approximately 15 μM in HeLa cells. Its derivative, Poloxin-2HT, developed by conjugating a hydrophobic tag (HT) to Poloxin-2, represents a novel application for inhibiting protein–protein interactions. Poloxin-2HT selectively degrades Plk1 protein, significantly enhancing its effects on cellular viability and apoptosis compared to untagged Poloxin-2. These findings validate hydrophobic tagging as a new strategy for targeting and disrupting disease-relevant proteins.